Bicycle Therapeutics PLC at Jefferies London Healthcare Conference Transcript
Good morning, everyone. Thank you for attending Jefferies London Healthcare Conference. My name is Kelly Shi, one of the biotech analysts at Jefferies.
It is our great pleasure to host Mr. Kevin Lee, CEO of Bicycle Therapeutics. We also have Mr. Lee Kalowski, CFO; and Dr. Nick Keen, Chief Scientific Officer; and Mr. Dominic Smethurst, Chief Medical Officer, for a fireside chat. Welcome, everyone.
Questions & Answers
And first, maybe would you like to give a brief introduction of the company and also discuss where do you see the application of Bicycle molecules to the broader space of drug development?
Hi. Thanks, Kelly. And many thanks to Jefferies for the invitation and, obviously, the audience for getting up so early this morning.
Bicycle is a company that was founded by Sir Greg Winter. Many of you all know Sir Greg Winter from his pioneering work in antibodies and peptides, and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |